Skip to Content

Tag: Vertess


News

In brief: CCS launches PropheSee, Vertess’ Smith recognized

June 12, 2024HME News Staff

DALLAS – CCS has launched PropheSee, an AI-powered predictive model for health care organizations focused on improving adherence in people with diabetes who use a continuous glucose monitoring (CGM) device.  With the deployment of this new predictive model, CCS has observed increases in adherence rates among targeted, high-risk patient cohorts by as much as 50% compared to control groups. The increase in adherence resulted from tech-enabled, personalized interventions based on risk...

CCS, Edgepark, Medtrade, Nymbl Systems, PropheSee, Vertess


Read Full Articlered right arrow icon

Brad Smith

Also Noted

Vertess partner recognized for deal

June 10, 2024HME News Staff

FORT WORTH, Texas – Vertess has announced that Bradley Smith, managing director/partner, has been recognized as an M&A advisor for one of Axial’s Top 8 Deals of 2023. Axial, a private deal network serving professionals who own, advise and invest in North American companies, named Smith’s deal a top transaction across the health care industry last year. He provided sell side representation for a medical device manufacturer in a transaction that took 12 months from signing to closing...

Brad Smith, Mergers & Acquisitions (M&A), Vertess


Read Full Articlered right arrow icon

News

In brief: SoCal’s new ‘powerful platform,’ Vertess’ recognition, WHILL’s growth 

May 10, 2024HME News Staff

TUSTIN, Calif. – SG Homecare, a provider of HME and supplies, has acquired Western Drug Medical Supply, creating a platform to scale in Southern California.  The combined entity has more than $150 million in annual revenue and more than 500 employees.  "This is a transformative moment for both SG Homecare and Western Drug Medical Supply," said Jay Wendt, CEO, SG Homecare. "We're committed to a seamless integration, fostering a powerful platform for growth....

SG Homecare, Vertess, Western Drug, WHILL


Read Full Articlered right arrow icon

Also Noted

Vertess recognized for dealmaking

May 9, 2024HME News Staff

FORT WORTH, Texas – Vertess was recently named the No. 1 lower middle market investment bank for Q1 2024 by Axial, a private deal network serving professionals who own, advise and invest in North American companies. Vertess facilitated three transactions in the quarter:  MyDoc Urgent Care, a multi-location urgent care center based in Pennsylvania, was acquired by MyTown Health Partners, a comprehensive practice management services organization recently formed by Webster Equity...

Vertess


Read Full Articlered right arrow icon

News

In brief: Vivos picks Lincare, industry wins in GA, Belluscura tries DTC

October 27, 2023HME News Staff

LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.  The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...

CAIRE, Lincare, Vertess, Vivos


Read Full Articlered right arrow icon

Brad Smith

Also Noted

Vertess announces pick up in M&A activity 

October 26, 2023HME News Staff

FORTH WORTH, Texas – Vertess has closed five major health care transactions in the third quarter of 2023 with a total value of $75 million. The transactions were in various health care verticals. "At the end of 2022 and early 2023, we saw a sharp decline in the pace of M&A activity,” said Brad Smith, managing director. “We continued to push forward and remain patient. We are pleased for our clients that our perseverance with buyers resulted in several successes." Vertess sees signs...

Vertess


Read Full Articlered right arrow icon

M&A: Get your stories straight 

Medtrade Show Daily

M&A: Get your stories straight 

March 29, 2023Theresa Flaherty, Managing Editor

DALLAS – While uncertainty in the broader economy has caused a slowdown in M&A, when buyers and sellers know what they want, deals are getting done, said experts at Medtrade on Tuesday.  “Why do you want to transact?” asked Brad Smith, managing director/partner at Vertess. “Why do you want to buy or sell? (If you’re selling), give a buyer enough information so they can make an educated decision. Make it a conversation. Have calls; get to know these people.”  Smith...

Brown & Fortunato, Medtrade, Mergers & Acquisitions (M&A), valuation, Vertess


Read Full Articlered right arrow icon

Jonathan Sadock

Providers

M&A analysts: ‘Focus on acquiring solid companies’

February 10, 2023Theresa Flaherty, Managing Editor

YARMOUTH, Maine – Industry analysts see steady deal-making in 2023, with a variety of companies making buys in both typically hot markets like respiratory and newly hot markets like repairs, but with more of a focus on due diligence.  “I think the interest is at both the national level, as well as the larger regionals, aggressively pursuing acquisitions,” said Pat Clifford, managing director, home medical equipment, for The Braff Group. “There is acquisition appetite...

Home Medical Equipment (HME), Paragon Ventures, Provident Healthcare Partners, The Braff Group, Vertess


Read Full Articlered right arrow icon

News

In brief: Part B drug payments, Kalogon deal, new Vertess managing director

January 6, 2023HME News Staff

WASHINGTON – CMS should bolster its oversight of manufacturer-submitted average sales price (ASP) data to ensure accurate Part B drug payments, according to a new report from the Office of Inspector General.   Due to invalid or missing ASP data, CMS could not calculate an ASP-based payment amount for 8% of drug codes at least once between 2016-20, the OIG found.  “CMS was unable to calculate an ASP-based payment amount for several reasons, including that (1)...

CMS, Home Medical Equipment (HME), Kalogon, Medicare, Merits Health Products, Vertess


Read Full Articlered right arrow icon

Also Noted

Vertess taps former MSC Biomedical exec as new managing director

January 4, 2023HME News Staff

FORT WORTH, Texas – Vertess recently hired Jonathan Hadley as their newest managing director. Hadley has experience in the medical device space after leading and growing MSC Biomedical, a large medical device service organization in North America, where he served in various roles, including CEO. At MSC Biomedical, Hadley was able to work directly with medical device manufacturers, HME providers and former competitors as he executed upon a national network acquisition M+A strategy. "I have been...

Home Medical Equipment (HME), Vertess


Read Full Articlered right arrow icon